Cpex Pharmaceuticals, Inc.
SEC CIK 1418919 · cpex · last insider filing 2011-04-07
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Spiegel John W | Director | filed 2008 - 2011 |
| Mcgovern Michael | Director | filed 2008 - 2011 |
| Murphy James R | Director | filed 2008 - 2011 |
| Forrester Robert | Director | filed 2010 - 2011 |
| Sedor John A | Director · President and CEO | filed 2008 - 2011 |
| Fernandez Miguel | Director | filed 2008 - 2009 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Hebert Robert P | Chief Financial Officer | filed 2008 - 2011 |
| Berman Lance | Chief Medical Officer | filed 2009 - 2011 |
| Bergenhem Nils | Chief Scientific Officer | filed 2010 - 2011 |
| Feldman Fred | SVP and Chief Science Officer | filed 2008 - 2009 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.